The Osgood-schlatter market insights and analysis by diagnosis, treatment, end user - forecast till 2030. Osgood-Schlatter disease (OSD), an inflammation of the knee and the surrounding area, is characterized by a painful lump just below the knee that becomes worse with activity. Teenagers who are growing, especially those going through growth spurts, are primarily affected by OSD. Sports and other physical activities, especially those that call for high degrees of intensity, such sprinting or leaping, are very common among people who participate in them.
Most of the time, OSD improves over time, especially with relaxing. OSD affects 4% of people at some point in their lifespan and is more common in males between the ages of 10 and 15 than females. There are around five times as many men as women. Knee pain, swelling, tenderness, an increase in temperature beneath the knee, among other symptoms, are all signs of OSD. In severe circumstances, OSD may lead to a fracture.
The development of healthcare and orthopaedic centers, the rise of sports culture, the expanding influence of sports media, the growth of physiotherapy and advances in medications and surgery, as well as the development of extreme sports like mountaineering and rock climbing, among other factors, are the market drivers for the global Osgood-Schlatter market. Market restraints include, among other things, treatment issues like pain and bleeding, high treatment costs, competition from alternative treatments, and the self-correcting nature of the ailment.
Market development represents the best strategy for the market growth. The market is expected to witness exponential growth over the review period owing to minimal invasive surgical procedures for the treatment of fractures associated with OSD.
The ideal approach for controlling the market is product development because the current drug treatment is expensive and full of negative effects. In developing nations like Africa and the Asia-Pacific, the price of the goods will be crucial. The biggest unmet need in the market is the rising demand for better, less invasive surgical techniques.
Global Osgood-Schlatter Market Players
Some of the key players profiled in the report are DJO Global, Inc., Teva Pharmaceutical Industries Ltd., Breg, Inc., Bayer HealthCare Pharmaceuticals LLC, Ossur HF, Daiichi Sankyo Company, Limited, Pfizer, Inc., Novartis AG, and others.
The global Osgood-Schlatter market trends has been segmented on the basis of diagnosis, treatment and end user.
Based on the diagnosis, the market has been segmented as physical examination, ultrasonography, X-ray, combination and other.
Based on the treatment, the market has been segmented as non-steroidal anti-inflammatory drugs, physical therapy, knee braces and supports, surgery and others.
Based on the end user, the market has been segmented as hospitals clinics, academic and research, and others.
The Americas accounts for a significant market share due to high expenditure on the health care and the large sports culture of the US. Additionally, the fastest uptake of new healthcare products in the US drives the Osgood-Schlatter market. Furthermore, concentration of the major healthcare companies and hospitals in the developed countries of this region coupled with large insurance penetration is adding fuel to the market growth. Moreover, the US expend high amount on its healthcare, which accounts for 16% of total GDP, which also increases the sale in Osgood-Schlatter market.
Europe is the second largest market in the world due to high income, strong healthcare penetration and rising popularity of sports such as soccer. The European market growth is led by countries such as Germany and France. The UK is expected to be the fastest growing market over the assessment period. The strong pharmaceutical industry in Germany is a strong driver behind the dominance of this country in Europe.
The large sporting culture and popularity of sports and media influence in the developed regions is expected to drive the future market. The development of extreme sports in the developed regions such as rock climbing, free running etc. is expected to develop the market in these regions.
Asia Pacific region is expected to grow rapidly; China and India are likely to lead this market due to fast growing healthcare sector and large unmet needs over the forecast period. South East Asian countries such as China, India, and Malaysia are projected to contribute highly to the market growth. The growing penetration of healthcare insurance in the Asia Pacific region is expected to drive the future Osgood-Schlatter market in the region.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East African market. Other Middle East nations to watch out for are Kuwait, Jordan, Egypt and Iran. The African region is expected to witness a moderate growth owing to poor economic and political conditions, and poor healthcare development.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)